Trials that use: Fisher exact test
New to this method? Read the tutorial →
4,441 results
- COAST-VIndependent statistical analysis of A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: Complete Statistical AnalysisIndependent statistical analysis of Cobiprostone Prevention of NSAID-induced Gastroduodenal Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00597818).
- Cochlear Implantation for Treatment of Single-sided Deafness: Complete Statistical AnalysisIndependent statistical analysis of Cochlear Implantation for Treatment of Single-sided Deafness: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02532972).
- Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery: Complete Statistical AnalysisIndependent statistical analysis of Cocoa Flavanols for Modulating Immune Response and Accelerating Recovery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03123068).
- COCOA-PADIndependent statistical analysis of Cocoa to Improve Walking Performance in Peripheral Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02876887).
- COCOVIndependent statistical analysis of Care Outcomes for Chiropractic Outpatient Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03254719).
- Code SepsisIndependent statistical analysis of Effects of Code Sepsis Implementation on Emergency Department (ED) Sepsis Care: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CoFAR7Independent statistical analysis of Baked Egg or Egg Oral Immunotherapy for Children With Egg Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COG STIMIndependent statistical analysis of Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol): primary endpoint results, effect estimate with confidence…
- Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Effects of Inhalational Versus Intravenous General Anesthesia in the Elderly: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Cognitive Remediation With D-Cycloserine: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Remediation With D-Cycloserine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01399866).
- Cognitive Training for Nicotine Dependence: Complete Statistical AnalysisIndependent statistical analysis of Cognitive Training for Nicotine Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01252966).
- ColdPlay2Independent statistical analysis of Evaluation of Effect of CryoBalloon Focal Ablation System on Human Esophageal Epithelium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Collaboration Live: Complete Statistical AnalysisIndependent statistical analysis of Collaboration Live: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04243369).
- Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: Complete Statistical AnalysisIndependent statistical analysis of Combination Antibiotic Treatment for Reactive Arthritis Caused by Chlamydia Bacteria: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00351273).
- Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer: primary endpoint…
- Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt’s Lymphoma or Leukemia: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer: primary…
- Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy, Autologous Stem Cell Transplant, and/or Radiation Therapy in Treating Young Patients With Extraocular Retinoblastoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy in Biochemically Recurrent Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03315871).
- Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: Complete Statistical AnalysisIndependent statistical analysis of Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01570036).
- Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: Complete Statistical AnalysisIndependent statistical analysis of Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01121939).
- Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: Complete Statistical AnalysisIndependent statistical analysis of Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): Complete Statistical AnalysisIndependent statistical analysis of Combination of GTI-2040 and Cytarabine in the Treatment of Refractory and Relapsed Acute Myeloid Leukemia (AML): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: Complete Statistical AnalysisIndependent statistical analysis of Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: Complete Statistical AnalysisIndependent statistical analysis of Combination Study of IPH2201 (Monalizumab) With Ibrutinib in Relapsed, Refractory or Previously Untreated CLL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: Complete Statistical AnalysisIndependent statistical analysis of Combination Therapy With Nivolumab and PD-L1/IDO Peptide Vaccine to Patients With Metastatic Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): Complete Statistical AnalysisIndependent statistical analysis of Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial): primary endpoint results, effect estimate…
- Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus: Complete Statistical AnalysisIndependent statistical analysis of Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01378377).
- Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep: Complete Statistical AnalysisIndependent statistical analysis of Combined Electroencephalogram, Magnetic Resonance Imaging-Positron Emission Tomography of Dexmedetomidine Induced Sleep: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Combined Immunochemotherapy Followed By Reduced Dose Radiation Therapy (RT) for Patients With Newly Diagnosed Primary Central Nervous System Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size…
- Combined Letrozole and Clomid in Women With Infertility and PCOS: Complete Statistical AnalysisIndependent statistical analysis of Combined Letrozole and Clomid in Women With Infertility and PCOS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02802865).
- Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis: Complete Statistical AnalysisIndependent statistical analysis of Combined MRI and Optical Imaging to Improved Breast Cancer Diagnosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00610467).
- Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation: Complete Statistical AnalysisIndependent statistical analysis of Combined Ruxolitinib and Enasidenib in Patients With Accelerated/Blast-phase Myeloproliferative Neoplasm or Chronic-phase Myelofibrosis With an IDH2 Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen: Complete Statistical AnalysisIndependent statistical analysis of Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen:…
- Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO): Complete Statistical AnalysisIndependent statistical analysis of Combining Broad Based Light (BBL), Fractionated 1927 (MOXI) and Dual Wavelength 2940/1470 (HALO): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00769184).
- Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC: Complete Statistical AnalysisIndependent statistical analysis of Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- COMETABreastIndependent statistical analysis of Analysis of Olaparib Response in Patients With BRCA1 and/or 2 Promoter Methylation Diagnosed of Advanced Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Common Safety Follow-up Trial of Tecemotide (L-BLP25): Complete Statistical AnalysisIndependent statistical analysis of Common Safety Follow-up Trial of Tecemotide (L-BLP25): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01423760).
- Community Care for Croup (RCT): Complete Statistical AnalysisIndependent statistical analysis of Community Care for Croup (RCT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01042145).